Patents by Inventor Johann Elbaz

Johann Elbaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Programmable artificial cell
    Patent number: 11421226
    Abstract: The present invention provides cell-free systems comprising: (i) a transcription compartment; (ii) a barrier; and (iii) a translation compartment, methods for producing proteins and performing post-translational modifications thereon using such systems, and kits comprising such systems.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: August 23, 2022
    Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Shai Zilberzwige-Tal, Ehud Gazit, Johann Elbaz
  • Compartmentalized Central Dogma Activities Within Artificial Cell
    Publication number: 20200123541
    Abstract: The present invention provides cell-free systems comprising: (i) a transcription compartment; (ii) a barrier; and (iii) a translation compartment, methods for producing proteins and performing post-translational modifications thereon using such systems, and kits comprising such systems.
    Type: Application
    Filed: October 16, 2019
    Publication date: April 23, 2020
    Inventors: Shai ZILBERZWIGE-TAL, Ehud GAZIT, Johann ELBAZ
  • Engineering DNA assembly in vivo and methods of making and using the reverse transcriptase technology
    Patent number: 9970040
    Abstract: Cells that can synthesize oligonucleotides in vivo to produce a nucleic acid nanostructure are described. Methods for producing oligonucleotide nanostructures for use in regulating gene expression and altering biological pathways are provided. Methods of performing multiplex automated genome editing (MAGE) are also provided.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: May 15, 2018
    Assignee: Massachusetts Institute of Technology
    Inventors: Johann Elbaz, Christopher Voigt
  • ENGINEERING DNA ASSEMBLY IN VIVO AND METHODS OF MAKING AND USING THE REVERSE TRANSCRIPTASE TECHNOLOGY
    Publication number: 20150184213
    Abstract: Cells that can synthesize oligonucleotides in vivo to produce a nucleic acid nanostructure are described. Methods for producing oligonucleotide nanostructures for use in regulating gene expression and altering biological pathways are provided. Methods of performing multiplex automated genome editing (MAGE) are also provided.
    Type: Application
    Filed: September 26, 2014
    Publication date: July 2, 2015
    Applicant: Massachusetts Institute of Technology
    Inventors: Johann Elbaz, Christopher Voigt